What This Means for Patients Prior Authorization Changes (August 1, 2024 - December 31, 2024): New prior authorization requests will be required
SURMOUNT-5s primary end point was to demonstrate superiority among individuals treated with Zepbound in percent change from baseline in body weight at study completion compared with Wegovy
Conf Proc IEEE Eng Med Biol Soc 2008:363366 Demarest TG, Schuh RA, Waite EL, Waddell J, McKenna MC, Fiskum G (2016) Sex dependent alterations in mitochondrial electron transport chain proteins following neonatal rat cerebral hypoxic-ischemia
Patients are advised to monitor for symptoms of thyroid tumors, including swelling of the neck, difficulty swallowing, or persistent hoarseness
Whats more, the better you understand how Wegovy can help, the greater the chance of long-term success with this exciting new aid to weight loss